PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15964302-14	2005	Pre-treatment with SB-203580, a p38 inhibitor, significantly reduced MLR stimulatory capacity of CypA-induced DCs in both CD8+ and CD4+ T cells (P < 0.05).	SB 203580	19-28	peptidylprolyl isomerase A	Homo sapiens	97-101	
29110442-6	2018	The p38 inhibitor SB203580 was used to show that p38 MAPK is involved in CypA-mediated NSCLC metastasis.	SB 203580	18-26	peptidylprolyl isomerase A	Homo sapiens	73-77	
29110442-10	2018	In addition, SB203580 inhibited NSCLC cell migration significantly in the CypA overexpressed group, while the difference in the CypA downregulated group was not significant.	SB 203580	13-21	peptidylprolyl isomerase A	Homo sapiens	74-78	
18567920-9	2008	CypA-induced nuclear factor kappaB (NF-kappaB) activity for MMP-9 transcription were strongly blocked by extracellular signal-regulated kinase (ERK), c-Jun amino terminal kinase (JNK) inhibitors (U0126 and SP600125, respectively), but not by p38 mitogen-activated protein kinase (MAPK) inhibitors (SB203580).	SB 203580	298-306	peptidylprolyl isomerase A	Homo sapiens	0-4